News

Rhythm Phar­ma­ceu­ti­cals is look­ing to ex­pand the po­ten­tial mar­ket for its rare obe­si­ty treat­ment Im­civree be­yond ge­net­ic dis­or­ders.
An exceptional example of wildlife photography, 'Birder Guard' by Daisymaye, has earned our 'Photo of the Week' (POTW) accolade. This image is superbly captured, showcasing a fine silhouetted ...
On Friday, The Centers for Medicare & Medicaid Services (CMS) did not finalize a provision to cover obesity drugs like Eli Lilly's LLY and Novo Nordisk’s NVO popular injections, Zepbound and ...
The US Centers for Medicare & Medicaid Services (CMS) confirmed that it will not proceed with a Biden administration proposal to expand Medicare coverage for anti-obesity drugs such as Novo ...
New Delhi: Edelweiss Mutual Funds CEO Radhika Gupta has suggested a practical solution to deal with the growing problem of obesity in India. Taking to social media platform X, she urged restaurants to ...
The Trump administration will not permit Medicare to pay for obesity drugs directly, declining on Friday to finalize a Biden-era proposal that would have allowed the federal health insurance ...
Investors remain enthusiastic about the market for obesity drugs. The GLP-1 drugs Wegovy and Zepbound recorded sales of $8.4 billion and $4.9 billion respectively in 2024. Their climbing sales, along ...
President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the federal government's Medicare program. The Centers for Medicare and Medicaid ...
President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the federal government's Medicare program. The Centers for Medicare and Medicaid ...
President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the federal government's Medicare program.
A government-sponsored junk food ban in schools across Mexico took effect on Saturday, officials said, as the country tries to tackle one of the world’s worst obesity and diabetes epidemics.